Notably, RFX transcription factors, including RFX116, have been implicated in tumor suppression17, suggesting that reduced binding of these transcription factors in the presence of PRDM6 may have oncogenic potential in NES cells. This evidence concerns the gene PRDM6 and neoplasm.